Samantha Pearce is VP at Jazz Pharmaceuticals plc (JAZZ). They have made 10 open-market trades across 1 company since 2022, most recently 2026-08-05.
CIK 0001805688
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JAZZ | 47,131 | $9.9M |
Shares reported on the most recent Form 4, priced at the 2026-08-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL | 2026-05-28 | 2026-06-01 | $235.41 | $1.6M | +1.9% | +2.5% | +8.3% |
| JAZZ | SELL | 2023-02-02 | 2023-02-06 | $157.26 | $167K | -4.3% | -8.5% | -9.3% |
| JAZZ | SELL | 2023-01-03 | 2023-01-05 | $159.59 | $169K | -3.2% | -4.3% | -8.9% |
| JAZZ | SELL | 2022-12-13 | 2022-12-15 | $155.45 | $165K | +2.8% | +2.1% | -11.6% |
| JAZZ | SELL | 2022-11-10 | 2022-11-14 | $155.00 | $165K | +2.1% | +5.1% | +1.0% |
| JAZZ | SELL | 2022-09-02 | 2022-09-07 | $156.98 | $167K | -2.1% | -10.2% | -0.9% |
| JAZZ | SELL | 2022-08-04 | 2022-08-08 | $155.00 | $82K | +1.2% | -1.7% | -6.0% |
| JAZZ | SELL | 2022-07-12 | 2022-07-14 | $155.00 | $82K | +1.6% | +2.7% | -16.0% |
| JAZZ | SELL | 2022-06-27 | 2022-06-29 | $155.00 | $1.3M | +0.3% | +1.3% | -17.8% |
| JAZZ | SELL | 2022-06-08 | 2022-06-10 | $155.00 | $1.3M | +4.5% | +7.9% | +5.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.